Can lisinopril (Angiotensin-Converting Enzyme (ACE) inhibitor) cause a dry cough?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 15, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Lisinopril and Dry Cough: Diagnosis and Management

Lisinopril definitively causes dry cough in 5-35% of patients, and this is a well-established class effect of all ACE inhibitors that requires discontinuation of the medication for resolution. 1

Mechanism and Clinical Presentation

ACE inhibitor-induced cough has several key characteristics:

  • Typically dry, non-productive cough
  • Associated with a tickling or scratching sensation in the throat
  • Not dose-dependent
  • Occurs more commonly in:
    • Women
    • Nonsmokers
    • Persons of Chinese origin 1

The mechanism involves:

  • Accumulation of bradykinin and substance P in the upper airway due to reduced degradation by ACE
  • Stimulation of prostaglandin production
  • Sensitization of airway sensory nerves 1

Timing and Diagnosis

The cough may:

  • Begin within hours of the first dose
  • Develop weeks to months after starting therapy
  • Persist as long as the medication is continued
  • Resolve within 1-4 weeks after discontinuation (though may take up to 3 months in some patients) 1

When evaluating a patient with cough on lisinopril:

  • Consider ACE inhibitors as causative regardless of the temporal relationship between medication initiation and cough onset
  • The diagnosis is confirmed by resolution of cough after discontinuation 1

Management Algorithm

  1. Discontinue lisinopril

    • This is the only uniformly effective treatment for ACE inhibitor-induced cough 1
    • Complete resolution typically occurs within 1-4 weeks but may take up to 3 months 1
  2. Switch to an angiotensin receptor blocker (ARB)

    • ARBs like valsartan or losartan have significantly lower incidence of cough compared to ACE inhibitors 2, 3
    • In clinical trials comparing ARBs to ACE inhibitors:
      • Valsartan: 2.6% cough incidence vs. 7.9% with ACE inhibitors 2
      • Losartan: 17-29% cough incidence vs. 62-69% with lisinopril (in patients with previous ACE inhibitor cough) 3
  3. Consider other antihypertensives if ARBs are not tolerated

    • Calcium channel blockers
    • Thiazide diuretics
    • Beta-blockers

Special Considerations

  • In rare cases, cough may spontaneously resolve despite continued ACE inhibitor therapy 4
  • Some patients may tolerate one ACE inhibitor but not another, though this is uncommon 5
  • Very rarely, ARBs may also cause cough in sensitive individuals 6

Pitfalls to Avoid

  1. Misattribution of cause: Don't assume all cough in patients on lisinopril is due to the medication. Consider other common causes like respiratory infections, asthma, GERD, or post-nasal drip 1

  2. Delayed recognition: ACE inhibitor cough may develop months after starting therapy, making the association less obvious 1

  3. Inadequate follow-up: Some patients may experience prolonged cough for up to 3 months after discontinuation 1

  4. Unnecessary testing: If the clinical picture is consistent with ACE inhibitor-induced cough, a trial of discontinuation is more appropriate than extensive diagnostic testing 1

By following this approach, you can effectively diagnose and manage lisinopril-induced cough while maintaining appropriate treatment for the patient's underlying condition.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.